Skip to main navigation Skip to search Skip to main content

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study

  • Armando Santoro
  • , Lorenza Rimassa
  • , Ivan Borbath
  • , Bruno Daniele
  • , Stefania Salvagni
  • , Jean Luc Van Laethem
  • , Hans Van Vlierberghe
  • , Jörg Trojan
  • , Frank T. Kolligs
  • , Alan Weiss
  • , Steven Miles
  • , Antonio Gasbarrini
  • , Monica Lencioni
  • , Luca Cicalese
  • , Morris Sherman
  • , Cesare Gridelli
  • , Peter Buggisch
  • , Guido Gerken
  • , Roland M. Schmid
  • , Corrado Boni
    • Nicola Personeni, Ziad Hassoun, Giovanni Abbadessa, Brian Schwartz, Reinhard Von Roemeling, Maria E. Lamar, Yinpu Chen, Camillo Porta

Research output: Contribution to journal › Article › peer-review

515   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science